Diamedica Therapeutics(DMAC)
$8.02-0.57 (-6.64%)
DMAC
Diamedica Therapeutics earnings date
$8.02
At close:-0.57 (-6.64%)
Want to see DMAC full AI Analyst Report?
Diamedica Therapeutics (DMAC) Earnings Dates, Call Summary & Reports
573 Followers
Earnings Data
- Estimated Report Date
- Mar 23, 2027
- Period Ending
- 2026 (Q4)
- Consensus EPS Forecast
- -0.24
- Last Year’s EPS
- -0.17
TBA (Not Confirmed)
Same Quarter Last Year
Diamedica Therapeutics (DMAC) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced.
DMAC Q3 2026 Earnings Report
DMAC Upcoming Earnings
Diamedica Therapeutics's next earnings date is estimated for March 23, 2027, based on past reporting schedules.
DMAC Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release | Slides | Play Transcript |
|---|---|---|---|---|---|---|---|
| Mar 23, 2027 | 2026 (Q4) | -0.24- | -0.17 | ― | ― | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -0.21-0.21 | -0.17 | -23.53% (-0.04) | ― | ||
| Aug 10, 2026 | 2026 (Q2) | -0.20-0.19 | -0.18 | -5.56% (-0.01) | ― | ||
| May 06, 2026 | 2026 (Q1) | -0.19-0.19 | -0.18 | -5.56% (-0.01) | ― | ||
| Mar 30, 2026 | 2025 (Q4) | -0.18-0.17 | -0.18 | 5.56% (+0.01) | ― | ||
| Nov 12, 2025 | 2025 (Q3) | -0.16-0.17 | -0.15 | -13.33% (-0.02) | ― | ||
| Aug 12, 2025 | 2025 (Q2) | -0.19-0.18 | -0.13 | -38.46% (-0.05) | ― | ||
| May 13, 2025 | 2025 (Q1) | -0.18-0.18 | -0.14 | -28.57% (-0.04) | ― | ||
| Mar 17, 2025 | 2024 (Q4) | -0.17-0.18 | -0.12 | -50.00% (-0.06) | ― | ― | |
| Nov 13, 2024 | 2024 (Q3) | -0.15-0.15 | -0.12 | -25.00% (-0.03) | ― | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous quarter.
Beat Missed
DMAC Earnings-Related Price Changes
| Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 12, 2026 | $9.33 | $8.79 | -5.79% |
| Aug 10, 2026 | $6.65 | $6.87 | +3.31% |
| May 06, 2026 | $6.52 | $6.53 | +0.15% |
| Mar 30, 2026 | $6.64 | $6.77 | +1.96% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after its recent earnings reports.
FAQ
When does Diamedica Therapeutics (DMAC) report earnings?
Diamedica Therapeutics (DMAC) is estimated to report earnings on Mar 23, 2027, TBA (Not Confirmed). The date is an estimate based on past reporting schedules and may change.
What is DMAC EPS forecast?
DMAC EPS forecast for the fiscal quarter 2026 (Q4) is -0.24.

